PubMed

Effect of Rosiglitazone, Metformin, and Glyburide on Bone Biomarkers in Patients with Type 2 Diabetes.

Zinman B, Haffner SM, Herman WH, Holman RR, Lachin JM, Kravitz BG, Paul G, Jones NP, Aftring RP, Viberti G, Kahn SE; the A Diabetes Outcome Progression Trial Study Group.

J Clin Endocrinol Metab. 2009 Oct 29. [Epub ahead of print]PMID: 19875477 [PubMed - as supplied by publisher]Related articles

Preeclampsia and risk of developing subsequent diabetes.

Carr DB, Newton KM, Utzschneider KM, Tong J, Gerchman F, Kahn SE, Easterling TR, Heckbert SR.

Hypertens Pregnancy. 2009 Aug;28(4):435-47.PMID: 19843005 [PubMed - in process]Related articles

Rosiglitazone Decreases C-Reactive Protein to a Greater Extent Relative to Glyburide and Metformin over Four-Years in Spite of Greater Weight Gain: Observations from ADOPT (A Diabetes Outcome Progression Trial).

Kahn SE, Haffner SM, Viberti G, Herman WH, Lachin JM, Kravitz BG, Yu D, Paul G, Holman RR, Zinman B; for the ADOPT Study Group.

Diabetes Care. 2009 Oct 16. [Epub ahead of print]PMID: 19808911 [PubMed - as supplied by publisher]Related articles

Regression from pre-diabetes to normal glucose regulation in the diabetes prevention program.

Perreault L, Kahn SE, Christophi CA, Knowler WC, Hamman RF; Diabetes Prevention Program Research Group.

Diabetes Care. 2009 Sep;32(9):1583-8. Epub 2009 Jul 8.PMID: 19587364 [PubMed - indexed for MEDLINE]Related articles

Body mass index is associated with increased creatinine clearance by a mechanism independent of body fat distribution.

Gerchman F, Tong J, Utzschneider KM, Zraika S, Udayasankar J, McNeely MJ, Carr DB, Leonetti DL, Young BA, de Boer IH, Boyko EJ, Fujimoto WY, Kahn SE.

J Clin Endocrinol Metab. 2009 Oct;94(10):3781-8. Epub 2009 Jul 7.PMID: 19584179 [PubMed - indexed for MEDLINE]Related articles

Preeclampsia and Risk of Developing Subsequent Diabetes.

Carr DB, Newton KM, Utzschneider KM, Tong J, Gerchman F, Kahn SE, Easterling TR, Heckbert SR.

Hypertens Pregnancy. 2009 May 1:1-13. [Epub ahead of print]PMID: 19412838 [PubMed - as supplied by publisher]Related articles

Glucose control in type 2 diabetes: still worthwhile and worth pursuing.

Kahn SE.

JAMA. 2009 Apr 15;301(15):1590-2. No abstract available. PMID: 19366780 [PubMed - indexed for MEDLINE]Related articles

Amyloid formation in human IAPP transgenic mouse islets and pancreas, and human pancreas, is not associated with endoplasmic reticulum stress.

Hull RL, Zraika S, Udayasankar J, Aston-Mourney K, Subramanian SL, Kahn SE.

Diabetologia. 2009 Jun;52(6):1102-11. Epub 2009 Apr 8.PMID: 19352619 [PubMed - indexed for MEDLINE]Related articles

The beta cell lesion in type 2 diabetes: there has to be a primary functional abnormality.

Kahn SE, Zraika S, Utzschneider KM, Hull RL.

Diabetologia. 2009 Jun;52(6):1003-12. Epub 2009 Mar 27. Review.PMID: 19326096 [PubMed - indexed for MEDLINE]Related articles

Differential effects of abdominal adipose tissue distribution on insulin sensitivity in black and white South African women.

Goedecke JH, Levitt NS, Lambert EV, Utzschneider KM, Faulenbach MV, Dave JA, West S, Victor H, Evans J, Olsson T, Walker BR, Seckl JR, Kahn SE.

Obesity (Silver Spring). 2009 Aug;17(8):1506-12. Epub 2009 Mar 19.PMID: 19300428 [PubMed - indexed for MEDLINE]Related articles

Association between the 4 bp proinsulin gene insertion polymorphism (IVS-69) and body composition in black South African women.

Berman P, Collins M, Baumgarten I, Seoighe C, Jennings CL, Joffe Y, Lambert EV, Levitt NS, Faulenbach MV, Kahn SE, Goedecke JH.

Obesity (Silver Spring). 2009 Jun;17(6):1298-300. Epub 2009 Feb 26.PMID: 19247282 [PubMed - indexed for MEDLINE]Related articles

Insulin response in relation to insulin sensitivity: an appropriate beta-cell response in black South African women.

Goedecke JH, Dave JA, Faulenbach MV, Utzschneider KM, Lambert EV, West S, Collins M, Olsson T, Walker BR, Seckl JR, Kahn SE, Levitt NS.

Diabetes Care. 2009 May;32(5):860-5. Epub 2009 Feb 5.PMID: 19196884 [PubMed - indexed for MEDLINE]Related articlesFree article

Oxidative stress is induced by islet amyloid formation and time-dependently mediates amyloid-induced beta cell apoptosis.

Zraika S, Hull RL, Udayasankar J, Aston-Mourney K, Subramanian SL, Kisilevsky R, Szarek WA, Kahn SE.

Diabetologia. 2009 Apr;52(4):626-35. Epub 2009 Jan 16.PMID: 19148619 [PubMed - indexed for MEDLINE]Related articles

Enhanced cortisol production rates, free cortisol, and 11beta-HSD-1 expression correlate with visceral fat and insulin resistance in men: effect of weight loss.

Purnell JQ, Kahn SE, Samuels MH, Brandon D, Loriaux DL, Brunzell JD.

Am J Physiol Endocrinol Metab. 2009 Feb;296(2):E351-7. Epub 2008 Dec 2.PMID: 19050176 [PubMed - indexed for MEDLINE]Related articles

The association of ENPP1 K121Q with diabetes incidence is abolished by lifestyle modification in the diabetes prevention program.

Moore AF, Jablonski KA, Mason CC, McAteer JB, Arakaki RF, Goldstein BJ, Kahn SE, Kitabchi AE, Hanson RL, Knowler WC, Florez JC; Diabetes Prevention Program Research Group.

J Clin Endocrinol Metab. 2009 Feb;94(2):449-55. Epub 2008 Nov 18.PMID: 19017751 [PubMed - indexed for MEDLINE]Related articles

Amyloid formation results in recurrence of hyperglycaemia following transplantation of human IAPP transgenic mouse islets.

Udayasankar J, Kodama K, Hull RL, Zraika S, Aston-Mourney K, Subramanian SL, Tong J, Faulenbach MV, Vidal J, Kahn SE.

Diabetologia. 2009 Jan;52(1):145-53. Epub 2008 Nov 11.PMID: 19002432 [PubMed - indexed for MEDLINE]Related articles

Oral disposition index predicts the development of future diabetes above and beyond fasting and 2-h glucose levels.

Utzschneider KM, Prigeon RL, Faulenbach MV, Tong J, Carr DB, Boyko EJ, Leonetti DL, McNeely MJ, Fujimoto WY, Kahn SE.

Diabetes Care. 2009 Feb;32(2):335-41. Epub 2008 Oct 28. Erratum in: Diabetes Care. 2009 Jul;32(7):1355. PMID: 18957530 [PubMed - indexed for MEDLINE]Related articlesFree article

An examination of beta-cell function measures and their potential use for estimating beta-cell mass.

Kahn SE, Carr DB, Faulenbach MV, Utzschneider KM.

Diabetes Obes Metab. 2008 Nov;10 Suppl 4:63-76. Review.PMID: 18834434 [PubMed - indexed for MEDLINE]Related articles

Assessing gene-treatment interactions at the FTO and INSIG2 loci on obesity-related traits in the Diabetes Prevention Program.

Franks PW, Jablonski KA, Delahanty LM, McAteer JB, Kahn SE, Knowler WC, Florez JC; Diabetes Prevention Program Research Group.

Diabetologia. 2008 Dec;51(12):2214-23. Epub 2008 Oct 7. Erratum in: Diabetologia. 2009 Jul;52(7):1456. PMID: 18839134 [PubMed - indexed for MEDLINE]Related articles

Prevention of diabetes in women with a history of gestational diabetes: effects of metformin and lifestyle interventions.

Ratner RE, Christophi CA, Metzger BE, Dabelea D, Bennett PH, Pi-Sunyer X, Fowler S, Kahn SE; Diabetes Prevention Program Research Group.

J Clin Endocrinol Metab. 2008 Dec;93(12):4774-9. Epub 2008 Sep 30.PMID: 18826999 [PubMed - indexed for MEDLINE]Related articles

Glucose control, macro- and microvascular disease, and the Food and Drug Administration: let's keep our eye on the ball.

Kahn SE, Cefalu WT.

J Clin Endocrinol Metab. 2008 Oct;93(10):3727-9. Epub 2008 Sep 2. No abstract available. PMID: 18765506 [PubMed - indexed for MEDLINE]Related articlesFree article

The prevention of type 2 diabetes.

Crandall JP, Knowler WC, Kahn SE, Marrero D, Florez JC, Bray GA, Haffner SM, Hoskin M, Nathan DM; Diabetes Prevention Program Research Group.

Nat Clin Pract Endocrinol Metab. 2008 Jul;4(7):382-93. Epub 2008 May 20. Review.PMID: 18493227 [PubMed - indexed for MEDLINE]Related articlesFree article

Analytic bias among certified methods for the measurement of hemoglobin A1c: a cause for concern?

Holmes EW, Erşahin C, Augustine GJ, Charnogursky GA, Gryzbac M, Murrell JV, McKenna KM, Nabhan F, Kahn SE.

Am J Clin Pathol. 2008 Apr;129(4):540-7.PMID: 18343780 [PubMed - indexed for MEDLINE]Related articlesFree article

Visceral adiposity, not abdominal subcutaneous fat area, is associated with an increase in future insulin resistance in Japanese Americans.

Hayashi T, Boyko EJ, McNeely MJ, Leonetti DL, Kahn SE, Fujimoto WY.

Diabetes. 2008 May;57(5):1269-75. Epub 2008 Feb 25.PMID: 18299316 [PubMed - indexed for MEDLINE]Related articlesFree article

Altered body composition in type 2 diabetes mellitus.

Heshka S, Ruggiero A, Bray GA, Foreyt J, Kahn SE, Lewis CE, Saad M, Schwartz AV; Look AHEAD Research Group.

Int J Obes (Lond). 2008 May;32(5):780-7. Epub 2008 Jan 29.PMID: 18227843 [PubMed - indexed for MEDLINE]Related articles

Modestly elevated glucose levels during pregnancy are associated with a higher risk of future diabetes among women without gestational diabetes mellitus.

Carr DB, Newton KM, Utzschneider KM, Tong J, Gerchman F, Kahn SE, Heckbert SR.

Diabetes Care. 2008 May;31(5):1037-9. Epub 2008 Jan 25.PMID: 18223032 [PubMed - indexed for MEDLINE]Related articlesFree article

Rosiglitazone-associated fractures in type 2 diabetes: an Analysis from A Diabetes Outcome Progression Trial (ADOPT).

Kahn SE, Zinman B, Lachin JM, Haffner SM, Herman WH, Holman RR, Kravitz BG, Yu D, Heise MA, Aftring RP, Viberti G; Diabetes Outcome Progression Trial (ADOPT) Study Group.

Diabetes Care. 2008 May;31(5):845-51. Epub 2008 Jan 25.PMID: 18223031 [PubMed - indexed for MEDLINE]Related articlesFree article

Adiponectin, change in adiponectin, and progression to diabetes in the Diabetes Prevention Program.

Mather KJ, Funahashi T, Matsuzawa Y, Edelstein S, Bray GA, Kahn SE, Crandall J, Marcovina S, Goldstein B, Goldberg R; Diabetes Prevention Program.

Diabetes. 2008 Apr;57(4):980-6. Epub 2008 Jan 11.PMID: 18192541 [PubMed - indexed for MEDLINE]Related articlesFree article

Reduced adipogenic gene expression in thigh adipose tissue precedes human immunodeficiency virus-associated lipoatrophy.

Kratz M, Purnell JQ, Breen PA, Thomas KK, Utzschneider KM, Carr DB, Kahn SE, Hughes JP, Rutledge EA, Van Yserloo B, Yukawa M, Weigle DS.

J Clin Endocrinol Metab. 2008 Mar;93(3):959-66. Epub 2007 Dec 18.PMID: 18089690 [PubMed - indexed for MEDLINE]Related articlesFree article

Elevated depression symptoms, antidepressant medicine use, and risk of developing diabetes during the diabetes prevention program.

Rubin RR, Ma Y, Marrero DG, Peyrot M, Barrett-Connor EL, Kahn SE, Haffner SM, Price DW, Knowler WC; Diabetes Prevention Program Research Group.

Diabetes Care. 2008 Mar;31(3):420-6. Epub 2007 Dec 10.PMID: 18071002 [PubMed - indexed for MEDLINE]Related articlesFree article

Within-subject variability of measures of beta cell function derived from a 2 h OGTT: implications for research studies.

Utzschneider KM, Prigeon RL, Tong J, Gerchman F, Carr DB, Zraika S, Udayasankar J, Montgomery B, Mari A, Kahn SE.

Diabetologia. 2007 Dec;50(12):2516-25. Epub 2007 Oct 11.PMID: 17928990 [PubMed - indexed for MEDLINE]Related articles

The dipeptidyl peptidase-4 inhibitor vildagliptin improves beta-cell function and insulin sensitivity in subjects with impaired fasting glucose.

Utzschneider KM, Tong J, Montgomery B, Udayasankar J, Gerchman F, Marcovina SM, Watson CE, Ligueros-Saylan MA, Foley JE, Holst JJ, Deacon CF, Kahn SE.

Diabetes Care. 2008 Jan;31(1):108-13. Epub 2007 Oct 1.PMID: 17909087 [PubMed - indexed for MEDLINE]Related articlesFree article

The Pro12Ala variant at the peroxisome proliferator-activated receptor gamma gene and change in obesity-related traits in the Diabetes Prevention Program.

Franks PW, Jablonski KA, Delahanty L, Hanson RL, Kahn SE, Altshuler D, Knowler WC, Florez JC; Diabetes Prevention Program Research Group.

Diabetologia. 2007 Dec;50(12):2451-60. Epub 2007 Sep 27.PMID: 17898990 [PubMed - indexed for MEDLINE]Related articlesFree article

Inhibition of glycosaminoglycan synthesis and protein glycosylation with WAS-406 and azaserine result in reduced islet amyloid formation in vitro.

Hull RL, Zraika S, Udayasankar J, Kisilevsky R, Szarek WA, Wight TN, Kahn SE.

Am J Physiol Cell Physiol. 2007 Nov;293(5):C1586-93. Epub 2007 Sep 5.PMID: 17804609 [PubMed - indexed for MEDLINE]Related articlesFree article

Relationship of liver enzymes to insulin sensitivity and intra-abdominal fat.

Wallace TM, Utzschneider KM, Tong J, Carr DB, Zraika S, Bankson DD, Knopp RH, Kahn SE.

Diabetes Care. 2007 Oct;30(10):2673-8. Epub 2007 Jul 31.PMID: 17666458 [PubMed - indexed for MEDLINE]Related articlesFree article

Differences in A1C by race and ethnicity among patients with impaired glucose tolerance in the Diabetes Prevention Program.

Herman WH, Ma Y, Uwaifo G, Haffner S, Kahn SE, Horton ES, Lachin JM, Montez MG, Brenneman T, Barrett-Connor E; Diabetes Prevention Program Research Group.

Diabetes Care. 2007 Oct;30(10):2453-7. Epub 2007 May 29.PMID: 17536077 [PubMed - indexed for MEDLINE]Related articlesFree article

Factors associated with diabetes onset during metformin versus placebo therapy in the diabetes prevention program.

Lachin JM, Christophi CA, Edelstein SL, Ehrmann DA, Hamman RF, Kahn SE, Knowler WC, Nathan DM; DDK Research Group.

Diabetes. 2007 Apr;56(4):1153-9.PMID: 17395752 [PubMed - indexed for MEDLINE]Related articlesFree article

Intra-abdominal fat accumulation predicts the development of the metabolic syndrome in non-diabetic Japanese-Americans.

Tong J, Boyko EJ, Utzschneider KM, McNeely MJ, Hayashi T, Carr DB, Wallace TM, Zraika S, Gerchman F, Leonetti DL, Fujimoto WY, Kahn SE.

Diabetologia. 2007 Jun;50(6):1156-60. Epub 2007 Mar 27.PMID: 17387445 [PubMed - indexed for MEDLINE]Related articles

Point: Recent long-term clinical studies support an enhanced role for thiazolidinediones in the management of type 2 diabetes.

Kahn SE, Zinman B.

Diabetes Care. 2007 Jun;30(6):1672-6. Epub 2007 Mar 10. No abstract available. PMID: 17351271 [PubMed - indexed for MEDLINE]Related articlesFree article

Progressive loss of beta-cell function leads to worsening glucose tolerance in first-degree relatives of subjects with type 2 diabetes.

Cnop M, Vidal J, Hull RL, Utzschneider KM, Carr DB, Schraw T, Scherer PE, Boyko EJ, Fujimoto WY, Kahn SE.

Diabetes Care. 2007 Mar;30(3):677-82.PMID: 17327340 [PubMed - indexed for MEDLINE]Related articlesFree article

Type 2 diabetes-associated missense polymorphisms KCNJ11 E23K and ABCC8 A1369S influence progression to diabetes and response to interventions in the Diabetes Prevention Program.

Florez JC, Jablonski KA, Kahn SE, Franks PW, Dabelea D, Hamman RF, Knowler WC, Nathan DM, Altshuler D.

Diabetes. 2007 Feb;56(2):531-6.PMID: 17259403 [PubMed - indexed for MEDLINE]Related articlesFree article

Identification of the amyloid-degrading enzyme neprilysin in mouse islets and potential role in islet amyloidogenesis.

Zraika S, Hull RL, Udayasankar J, Clark A, Utzschneider KM, Tong J, Gerchman F, Kahn SE.

Diabetes. 2007 Feb;56(2):304-10. Erratum in: Diabetes. 2007 Jun;56(6):1746. PMID: 17259373 [PubMed - indexed for MEDLINE]Related articlesFree article

Glucose- and time-dependence of islet amyloid formation in vitro.

Zraika S, Hull RL, Udayasankar J, Utzschneider KM, Tong J, Gerchman F, Kahn SE.

Biochem Biophys Res Commun. 2007 Mar 2;354(1):234-9. Epub 2007 Jan 2.PMID: 17222388 [PubMed - indexed for MEDLINE]Related articlesFree article

Effects of the type 2 diabetes-associated PPARG P12A polymorphism on progression to diabetes and response to troglitazone.

Florez JC, Jablonski KA, Sun MW, Bayley N, Kahn SE, Shamoon H, Hamman RF, Knowler WC, Nathan DM, Altshuler D; Diabetes Prevention Program Research Group.

J Clin Endocrinol Metab. 2007 Apr;92(4):1502-9. Epub 2007 Jan 9.PMID: 17213274 [PubMed - indexed for MEDLINE]Related articlesFree article

Minimum waist and visceral fat values for identifying Japanese Americans at risk for the metabolic syndrome.

Hayashi T, Boyko EJ, McNeely MJ, Leonetti DL, Kahn SE, Fujimoto WY.

Diabetes Care. 2007 Jan;30(1):120-7.PMID: 17192344 [PubMed - indexed for MEDLINE]Related articlesFree article

Plasma pancreatic polypeptide levels are associated with differences in body fat distribution in human subjects.

Tong J, Utzschneider KM, Carr DB, Zraika S, Udayasankar J, Gerchman F, Knopp RH, Kahn SE.

Diabetologia. 2007 Feb;50(2):439-42. Epub 2006 Dec 15.PMID: 17171555 [PubMed - indexed for MEDLINE]Related articles

Mechanisms linking obesity to insulin resistance and type 2 diabetes.

Kahn SE, Hull RL, Utzschneider KM.

Nature. 2006 Dec 14;444(7121):840-6. Review.PMID: 17167471 [PubMed - indexed for MEDLINE]Related articles

Glycemic durability of rosiglitazone, metformin, or glyburide monotherapy.

Kahn SE, Haffner SM, Heise MA, Herman WH, Holman RR, Jones NP, Kravitz BG, Lachin JM, O'Neill MC, Zinman B, Viberti G; ADOPT Study Group.

N Engl J Med. 2006 Dec 7;355(23):2427-43. Epub 2006 Dec 4. Erratum in: N Engl J Med. 2007 Mar 29;356(13):1387-8. PMID: 17145742 [PubMed - indexed for MEDLINE]Related articlesFree article

Superiority of the Modification of Diet in Renal Disease equation over the Cockcroft-Gault equation in screening for impaired kidney function in Japanese Americans.

Gerchman F, Tong J, Utzschneider KM, Hull RL, Zraika S, Udayasankar J, McNeely MJ, Andress DL, Leonetti DL, Boyko EJ, Fujimoto WY, Kahn SE.

Diabetes Res Clin Pract. 2007 Aug;77(2):320-6. Epub 2006 Dec 4.PMID: 17141914 [PubMed - indexed for MEDLINE]Related articlesFree article

Effects of sex and hormone replacement therapy use on the prevalence of isolated impaired fasting glucose and isolated impaired glucose tolerance in subjects with a family history of type 2 diabetes.

van Genugten RE, Utzschneider KM, Tong J, Gerchman F, Zraika S, Udayasankar J, Boyko EJ, Fujimoto WY, Kahn SE; American Diabetes Association GENNID Study Group.

Diabetes. 2006 Dec;55(12):3529-35.PMID: 17130501 [PubMed - indexed for MEDLINE]Related articlesFree article